keyword
https://read.qxmd.com/read/38734190/repurposing-of-antimycobacterium-drugs-for-covid-19-treatment-by-targeting-sars-cov-2-main-protease-an-in-silico-perspective
#21
JOURNAL ARTICLE
Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, Subhashree Barik, Ashis Biswas, Snehasis Chowdhuri
The global mortality rate has been significantly impacted by the COVID-19 pandemic, caused by the SARS CoV-2 virus. Although the pursuit for a potent antiviral is still in progress, experimental therapies based on repurposing of existing drugs is being attempted. One important therapeutic target for COVID-19 is the main protease (Mpro) that cleaves the viral polyprotein in its replication process. Recently minocycline, an antimycobacterium drug, has been successfully implemented for the treatment of COVID-19 patients...
May 9, 2024: Gene
https://read.qxmd.com/read/38734015/switch-to-fixed-dose-doravirine-100-mg-with-islatravir-0%C3%A2-75-mg-once-daily-in-virologically-suppressed-adults-with-hiv-1-on-antiretroviral-therapy-48-week-results-of-a-phase-3-randomised-open-label-non-inferiority-trial
#22
JOURNAL ARTICLE
Jean-Michel Molina, Giuliano Rizzardini, Catherine Orrell, Alejandro Afani, Alexandra Calmy, Shinichi Oka, Federico Hinestrosa, Princy Kumar, Pablo Tebas, Sharon Walmsley, Anjana Grandhi, Stephanie Klopfer, Isaias Gendrano, Karen Eves, Todd A Correll, Michelle C Fox, Jason Kim
BACKGROUND: Doravirine and islatravir is an investigational, once-daily, single-tablet regimen with high antiviral potency, favourable safety and tolerability, and low propensity for resistance. We report week 48 results from a phase 3 trial evaluating switch from stable, oral antiretroviral therapy (ART) to the fixed combination of doravirine (100 mg) and islatravir (0·75 mg). METHODS: This phase 3, multicentre, randomised, active-controlled, open-label, non-inferiority trial was conducted at 77 research, community, and hospital-based clinics in 15 countries...
May 8, 2024: Lancet HIV
https://read.qxmd.com/read/38733546/label-free-quantitative-proteomic-profiling-of-serum-samples-of-intellectually-disabled-young-patients-revealed-dysregulation-of-complement-coagulation-and-cholesterol-cascade-systems
#23
JOURNAL ARTICLE
Soma Vankwani, Munazza Raza Mirza, Fazli Rabbi Awan, Muneeza Zafar, Arkadiusz Nawrocki, Muhammad Wasim, Haq Nawaz Khan, Hina Ayesha, Martin Rossel Larsen, Muhammad Iqbal Choudhary
Intellectual disability is a heterogeneous disorder, diagnosed using intelligence quotient (IQ) score criteria. Currently, no specific clinical test is available to diagnose the disease and its subgroups due to inadequate understanding of the pathophysiology. Therefore, current study was designed to explore the molecular mechanisms involved in disease perturbation, and to identify potential biomarkers for disease diagnosis and prognosis. A total of 250 participants were enrolled in this study, including 200 intellectually disabled (ID) subjects from the subgroups (mild, moderate, and severe) with age and gender matched healthy controls (n = 50)...
May 11, 2024: Metabolic Brain Disease
https://read.qxmd.com/read/38733464/screening-of-lactic-acid-bacteria-strains-for-potential-sourdough-and-bread-applications-enzyme-expression-and-exopolysaccharide-production
#24
JOURNAL ARTICLE
YiNing Dong, Jennifer Ronholm, Ismail Fliss, Salwa Karboune
Twenty-eight strains of lactic acid bacteria (LAB) were characterized for the ability to express enzymes of interest (including protease, xylanase, α-amylase, laccase, and glucose oxidase) as well as the ability to produce exopolysaccharide (EPS). The screening of enzyme capability for all LAB strains proceeded in a progressive 3-stage manner that helps to profile the efficiency of LAB strains in expressing chosen enzymes (Stage 1), highlights the strains with affinity for flour as the substrate (Stage 2), and discerns strains that can adapt well in a simulated starter environment (Stage 3)...
May 11, 2024: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/38732465/endophytic-fungi-residing-within-cornus-florida-l-in-mid-tennessee-phylogenetic-diversity-enzymatic-properties-and-potential-role-in-plant-health
#25
JOURNAL ARTICLE
Asha Maheshwari, Margaret T Mmbaga
Endophytic fungi that reside internally in healthy, asymptomatic plants often benefit their hosts by promoting plant growth and/or providing plant protection against abiotic and biotic stresses. However, only a small fraction of the estimated 1.5 million fungal endophytes have been identified. In this study, a total of 369 isolates of fungal endophytes in 59 distinct taxa were isolated from stem samples of Cornus florida (flowering dogwood). All isolates belonged to species of phyla Ascomycota and Basidiomycota distributed across five orders and 11 genera...
April 30, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38732454/potyviral-helper-component-protease-multifaced-functions-and-interactions-with-host-proteins
#26
REVIEW
Veronika Hýsková, Kateřina Bělonožníková, Josef Chmelík, Hana Hoffmeisterová, Noemi Čeřovská, Tomáš Moravec, Helena Ryšlavá
The best-characterized functional motifs of the potyviral Helper-Component protease (HC-Pro) responding for aphid transmission, RNA silencing suppression, movement, symptom development, and replication are gathered in this review. The potential cellular protein targets of plant virus proteases remain largely unknown despite their multifunctionality. The HC-Pro catalytic domain, as a cysteine protease, autoproteolytically cleaves the potyviral polyproteins in the sequence motif YXVG/G and is not expected to act on host targets; however, 146 plant proteins in the Viridiplantae clade containing this motif were searched in the UniProtKB database and are discussed...
April 29, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38731993/secreted-aspartic-proteinases-key-factors-in-candida-infections-and-host-pathogen-interactions
#27
REVIEW
Grazyna Bras, Dorota Satala, Magdalena Juszczak, Kamila Kulig, Ewelina Wronowska, Aneta Bednarek, Marcin Zawrotniak, Maria Rapala-Kozik, Justyna Karkowska-Kuleta
Extracellular proteases are key factors contributing to the virulence of pathogenic fungi from the genus Candida . Their proteolytic activities are crucial for extracting nutrients from the external environment, degrading host defenses, and destabilizing the internal balance of the human organism. Currently, the enzymes most frequently described in this context are secreted aspartic proteases (Saps). This review comprehensively explores the multifaceted roles of Saps, highlighting their importance in biofilm formation, tissue invasion through the degradation of extracellular matrix proteins and components of the coagulation cascade, modulation of host immune responses via impairment of neutrophil and monocyte/macrophage functions, and their contribution to antifungal resistance...
April 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38731848/host-microbiome-crosstalk-in-chronic-wound-healing
#28
REVIEW
Mara Mădălina Mihai, Beatrice Bălăceanu-Gurău, Ana Ion, Alina Maria Holban, Cristian-Dorin Gurău, Marius Nicolae Popescu, Cristina Beiu, Liliana Gabriela Popa, Mircea Ioan Popa, Cerasella Cristiana Dragomirescu, Mădălina Preda, Alexandru-Andrei Muntean, Ioana Sabina Macovei, Veronica Lazăr
The pathogenesis of chronic wounds (CW) involves a multifaceted interplay of biochemical, immunological, hematological, and microbiological interactions. Biofilm development is a significant virulence trait which enhances microbial survival and pathogenicity and has various implications on the development and management of CW. Biofilms induce a prolonged suboptimal inflammation in the wound microenvironment, associated with delayed healing. The composition of wound fluid (WF) adds more complexity to the subject, with proven pro-inflammatory properties and an intricate crosstalk among cytokines, chemokines, microRNAs, proteases, growth factors, and ECM components...
April 24, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38731411/integrating-explicit-and-implicit-fullerene-models-into-unres-force-field-for-protein-interaction-studies
#29
JOURNAL ARTICLE
Natalia H Rogoża, Magdalena A Krupa, Pawel Krupa, Adam K Sieradzan
Fullerenes, particularly C60 , exhibit unique properties that make them promising candidates for various applications, including drug delivery and nanomedicine. However, their interactions with biomolecules, especially proteins, remain not fully understood. This study implements both explicit and implicit C60 models into the UNRES coarse-grained force field, enabling the investigation of fullerene-protein interactions without the need for restraints to stabilize protein structures. The UNRES force field offers computational efficiency, allowing for longer timescale simulations while maintaining accuracy...
April 23, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38730718/susceptibility-of-melanoma-cells-to-targeted-therapy-correlates-with-protection-by-blood-neutrophils
#30
JOURNAL ARTICLE
Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel, Sophia Kreft, Teresa Kilian, Sarah Junker, Luisa Schmid, Tobias Sinnberg, Ulrich Dischinger, Markus V Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Luise Erpenbeck, Elsa Neubert, Matthias Goebeler, Anja Gesierich, David Schrama, Corinna Kosnopfel, Bastian Schilling
Elevated levels of peripheral blood and tumor tissue neutrophils are associated with poorer clinical response and therapy resistance in melanoma. The underlying mechanism and the role of neutrophils in targeted therapy is still not fully understood. Serum samples of patients with advanced melanoma were collected and neutrophil-associated serum markers were measured and correlated with response to targeted therapy. Blood neutrophils from healthy donors and patients with advanced melanoma were isolated, and their phenotypes, as well as their in vitro functions, were compared...
May 2, 2024: Cancers
https://read.qxmd.com/read/38730705/antiretroviral-drug-repositioning-for-glioblastoma
#31
JOURNAL ARTICLE
Sarah R Rivas, Mynor J Mendez Valdez, Jay S Chandar, Jelisah F Desgraves, Victor M Lu, Leo Ampie, Eric B Singh, Deepa Seetharam, Christian K Ramsoomair, Anna Hudson, Shreya M Ingle, Vaidya Govindarajan, Tara T Doucet-O'Hare, Catherine DeMarino, John D Heiss, Avindra Nath, Ashish H Shah
Outcomes for glioblastoma (GBM) remain poor despite standard-of-care treatments including surgical resection, radiation, and chemotherapy. Intratumoral heterogeneity contributes to treatment resistance and poor prognosis, thus demanding novel therapeutic approaches. Drug repositioning studies on antiretroviral therapy (ART) have shown promising potent antineoplastic effects in multiple cancers; however, its efficacy in GBM remains unclear. To better understand the pleiotropic anticancer effects of ART on GBM, we conducted a comprehensive drug repurposing analysis of ART in GBM to highlight its utility in translational neuro-oncology...
April 30, 2024: Cancers
https://read.qxmd.com/read/38730234/aptameric-hirudins-as-selective-and-reversible-exosite-active-site-exact-inhibitors
#32
JOURNAL ARTICLE
Haixiang Yu, Shekhar Kumar, James W Frederiksen, Vladimir N Kolyadko, George Pitoc, Juliana Layzer, Amy Yan, Rachel Rempel, Samuel Francis, Sriram Krishnaswamy, Bruce A Sullenger
Potent and selective inhibition of the structurally homologous proteases of coagulation poses challenges for drug development. Hematophagous organisms frequently accomplish this by fashioning peptide inhibitors combining exosite and active site binding motifs. Inspired by this biological strategy, we create several EXACT inhibitors targeting thrombin and factor Xa de novo by linking EXosite-binding aptamers with small molecule ACTive site inhibitors. The aptamer component within the EXACT inhibitor (1) synergizes with and enhances the potency of small-molecule active site inhibitors by many hundred-fold (2) can redirect an active site inhibitor's selectivity towards a different protease, and (3) enable efficient reversal of inhibition by an antidote that disrupts bivalent binding...
May 10, 2024: Nature Communications
https://read.qxmd.com/read/38730068/antiviral-anti-inflammatory-and-antioxidant-effects-of-curcumin-and-curcuminoids-in-sh-sy5y-cells-infected-by-sars-cov-2
#33
JOURNAL ARTICLE
Tiago Nicoliche, Cynthia Silva Bartolomeo, Robertha Mariana Rodrigues Lemes, Gabriela Cruz Pereira, Tamires Alves Nunes, Rafaela Brito Oliveira, Arthur Luiz Miranda Nicastro, Érica Novaes Soares, Brenno Fernandes da Cunha Lima, Beatriz Moreira Rodrigues, Juliana Terzi Maricato, Liria Hiromi Okuda, Mirela Inês de Sairre, Carla Máximo Prado, Rodrigo Portes Ureshino, Roberta Sessa Stilhano
COVID-19, caused by SARS-CoV-2, affects neuronal cells, causing several symptoms such as memory loss, anosmia and brain inflammation. Curcuminoids (Me08 e Me23) and curcumin (CUR) are derived from Curcuma Longa extract (EXT). Many therapeutic actions have been linked to these compounds, including antiviral action. Given the severe implications of COVID-19, especially within the central nervous system, our study aims to shed light on the therapeutic potential of curcuminoids against SARS-CoV-2 infection, particularly in neuronal cells...
May 10, 2024: Scientific Reports
https://read.qxmd.com/read/38729436/ionizable-lipid-nanoparticles-for-ras-protease-delivery-to-inhibit-cancer-cell-proliferation
#34
JOURNAL ARTICLE
Ella Atsavapranee, Rebecca M Haley, Margaret M Billingsley, Alexander Chan, Biao Ruan, Christian G Figueroa-Espada, Ningqiang Gong, Alvin J Mukalel, Philip N Bryan, Michael J Mitchell
Mutations in RAS, a family of proteins found in all human cells, drive a third of cancers, including many pancreatic, colorectal, and lung cancers. However, we lack clinical therapies that can effectively prevent RAS from causing tumor growth. Recently, a protease was engineered that specifically degrades active RAS, offering a promising new tool for treating these cancers. However, like many other intracellularly acting protein-based therapies, this protease requires a delivery vector to be delivered to its site of action within the cell...
May 8, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38728662/targeting-cellular-cathepsins-inhibits-hepatitis-e-virus-entry
#35
JOURNAL ARTICLE
Mara Klöhn, Thomas Burkard, Juliana Janzen, Jil Alexandra Haase, André Gömer, Rebecca Fu, George Ssebyatika, Maximilian K Nocke, Richard J P Brown, Thomas Krey, Viet Loan Dao Thi, Volker Kinast, Yannick Brüggemann, Daniel Todt, Eike Steinmann
BACKGROUND AND AIMS: The hepatitis E virus (HEV) is estimated to be responsible for 70,000 deaths annually, yet therapy options remain limited. In the pursuit of effective antiviral therapies, targeting viral entry holds promise and has proven effective for other viruses. However, the precise mechanisms and host factors required during HEV entry remain unclear. Cellular proteases have emerged as host factors required for viral surface protein activation and productive cell entry by many viruses...
May 10, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38728643/drug-repurposing-identification-of-sars-cov-2-potential-inhibitors-by-virtual-screening-and-pharmacokinetics-strategies
#36
JOURNAL ARTICLE
Zubia Rashid, Amal Fatima, Areeba Khan, Jennifer Matthew, Muhammad Z Yousaf, Neha Nadeem, Tarique N Hasan, Mati Ur Rehman, Syed S Naqvi, Saad J Khan
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic caused global health, economic, and population loss. Variants of the coronavirus contributed to the severity of the disease and persistent rise in infections. This study aimed to identify potential drug candidates from fifteen approved antiviral drugs against SARS-CoV-2 (6LU7), SARS-CoV (5B6O), and SARS-CoV-2 spike protein (6M0J) using virtual screening and pharmacokinetics to gain insights into COVID-19 therapeutics. METHODOLOGY: We employed drug repurposing approach to analyze binding performance of fifteen clinically approved antiviral drugs against the main protease of SARS-CoV-2 (6LU7), SARS-CoV (5B6O), and SARS-CoV-2 spike proteins bound to ACE-2 receptor (6M0J), to provide an insight into the therapeutics of COVID-19...
April 30, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38728448/plasmapheresis-combined-with-rituximab-treatment-of-a-case-of-thrombotic-thrombocytopenic-purpura-with-sj%C3%A3-gren-syndrome-and-renal-impairment-a-case-report
#37
JOURNAL ARTICLE
Yongqiang Zhang, Shanshan Hu, Yiyao Deng, Zhi Yang, Jing Yuan
RATIONALE: Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy caused by reduced activity of the von Willebrand factor-cleaving protease (ADAMTS13), which can be life-threatening. The patient reported in this case study also had concurrent Sjögren syndrome and renal impairment, presenting multiple symptoms and posing a great challenge in treatment. PATIENT CONCERNS: A 25-year-old woman in the postpartum period visited the hospital due to indifference in consciousness for more than 1 day following cesarean section 8 days prior...
May 10, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38728335/predicting-drug-protein-interaction-with-deep-learning-framework-for-molecular-graphs-and-sequences-potential-candidates-against-sar-cov-2
#38
JOURNAL ARTICLE
Weian Du, Liang Zhao, Rong Wu, Boning Huang, Si Liu, Yufeng Liu, Huaiqiu Huang, Ge Shi
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 disease, which represents a new life-threatening disaster. Regarding viral infection, many therapeutics have been investigated to alleviate the epidemiology such as vaccines and receptor decoys. However, the continuous mutating coronavirus, especially the variants of Delta and Omicron, are tended to invalidate the therapeutic biological product. Thus, it is necessary to develop molecular entities as broad-spectrum antiviral drugs...
2024: PloS One
https://read.qxmd.com/read/38727988/heterologous-expression-of-p9-from-akkermansia-muciniphila-increases-the-glp-1-secretion-of-intestinal-l-cells
#39
JOURNAL ARTICLE
Wenxuan Di, Yuchen Zhang, Xinyuan Zhang, Luxuan Han, Liang Zhao, Yanling Hao, Zhengyuan Zhai
Glucagon-like peptide-1(GLP-1) is an incretin hormone secreted primarily from the intestinal L-cells in response to meals. GLP-1 is a key regulator of energy metabolism and food intake. It has been proven that P9 protein from A. muciniphila could increase GLP-1 release and improve glucose homeostasis in HFD-induced mice. To obtain an engineered Lactococcus lactis which produced P9 protein, mature polypeptide chain of P9 was codon-optimized, fused with N-terminal signal peptide Usp45, and expressed in L. lactis NZ9000...
May 10, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38727974/unlocking-the-potential-of-spent-coffee-grounds-via-a-comprehensive-biorefinery-approach-production-of-microbial-oil-and-carotenoids-under-fed-batch-fermentation
#40
JOURNAL ARTICLE
Elena Anagnostopoulou, Erminta Tsouko, Sofia Maina, Eleni D Myrtsi, Serkos Haroutounian, Seraphim Papanikolaou, Apostolos Koutinas
The valorization of renewable feedstock to produce a plethora of value-added products could promote the transition towards a circular bioeconomy. This study presents the development of cascade processes to bioconvert spent coffee grounds (SCGs) into microbial oil and carotenoids employing sustainable practices. The stepwise recovery of crude phenolic extract and coffee oil was carried out using green or recyclable solvents, i.e., aqueous ethanol and hexane. Palmitic acid (43.3%) and linoleic acid (38.9%) were the major fatty acids in the oil fraction of SCGs...
May 10, 2024: Environmental Science and Pollution Research International
keyword
keyword
63649
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.